Table 5.
The average amount of electrolytes intake (mg) in the supplementation and placebo groups
| Variables | Measurement stage | Supplementation group (n=45) | Placebo group (n=45) | P-value |
|---|---|---|---|---|
| Na | At baseline | 1,792±692 | 1,854±676 | >0.05 |
| 4th week | 1,619±573 | 1,729±573 | ||
| 6th week | 1,694±401 | 1,694±401 | ||
| Mg | At baseline | 180±87 | 196±87 | >0.05 |
| 4th week | 194±92 | 187±92 | ||
| 6th week | 193±87 | 176±87 | ||
| K | At baseline | 1,599±54 | 1,702±54 | <0.05a, <0.05b |
| 4th week | 1,703±67 | 1,698±71 | ||
| 6th week | 1,750±78 | 1,703±73 | ||
| Ca | At baseline | 954±78 | 914±82 | <0.05a, <0.05b |
| 4th week | 984±73 | 965±56 | ||
| 6th week | 1,003±68 | 973±48 | ||
| P | At baseline | 953±78 | 878±68 | >0.05 |
| 4th week | 944±71 | 980±67 | ||
| 6th week | 860±68 | 860±54 | ||
| Fe | At baseline | 37±4 | 38±4 | >0.05 |
| 4th week | 35±3 | 39±3 | ||
| 6th week | 36±8 | 42±8 | ||
| Zn | At baseline | 17±4 | 16±4 | >0.05 |
| 4th week | 18±7 | 19±7 | ||
| 6th week | 18±8 | 17±8 | ||
| Mn | At baseline | 1.3±0.7 | 1.7±0.4 | >0.05 |
| 4th week | 1.5±0.8 | 1.8±0.8 | ||
| 6th week | 1.5±0.8 | 1.4±0.5 | ||
| Se | At baseline | 0.02±0.01 | 0.03±0.02 | <0.001a, <0.05b |
| 4th week | 0.02±0.01 | 0.02±0.01 | ||
| 6th week | 0.01±0.01 | 0.02±0.02 | ||
| Cr | At baseline | 0.01±0.001 | 0.03±0.001 | >0.05 |
| 4th week | 0.02±0.001 | 0.07±0.001 | ||
| 6th week | 0.04±0.003 | 0.05±0.003 | ||
| Mo | At baseline | 45.43±12.01 | 47.39±12.01 | >0.05 |
| 4th week | 47.5±11.2 | 48.6±10.2 | ||
| 6th week | 42.67±10.71 | 45.77±11.71 |
Notes:
a
Independent-sample t-test significant difference in the 6th week between groups.
b
Repeated measures ANOVA significant difference in the supplementation and placebo groups. Data are presented as mean ± SD.
Abbreviations: ANOVA, analysis of variance; SD, standard deviation.